AKT1 and gastric cancer: Within the cellular pathway, CBL-b plays a pivotal role in reversing multidrug resistance (MDR) in gastric cancer by inhibiting the PI3K/Akt signaling pathway and down-regulating the expression of P-glycoprotein (P-gp).